Jeff, Chairman of Papua New Guinea's Kennedy Group, and His Delegation Visit Bio-Sincerity to Discuss Development Cooperation

Jeff, Chairman of Kennedy Group from Papua New Guinea, and his delegation visited Bio-Sincerity on February 5, 2025 to discuss development cooperation. Lou Jinfang, Chairman and General Manager of Bio-Sincerity, received the delegation and accompanied them during the visit and exchanges.

The two parties exchanged views on exploring the pharmaceutical markets in Papua New Guinea and relevant Pacific island countries, and discussed the market development, cooperation models and future development directions of pharmaceutical formulation products.

Mr. Jeff stated that Papua New Guinea and surrounding Pacific island countries have a strong demand for high-quality pharmaceutical products. He expressed expectations for cooperating with Bio-Sincerity to introduce high-quality medicines that meet international standards, thereby contributing to the development of local public health undertakings.

Chairman Lou mentioned that Bio-Sincerity boasts rich R&D experience, mature technology platforms and an internationalized quality management system, which enables the company to meet international market demands. The two parties have broad cooperation space in areas such as market access, standard formulation and supply chain construction. She expressed the hope of strengthening exchanges to achieve mutual development.

This exchange marks a key step for Bio-Sincerity in expanding into the pharmaceutical market of the Pacific region and lays a solid foundation for future cooperation between the two parties. Bio-Sincerity will continue to adhere to its international development strategy, join hands with global partners, and contribute more to promoting the global pharmaceutical and health cause.